A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy

(2018) Paolo Andrea Zucali et al.   JOURNAL OF CLINICAL ONCOLOGY

Pure red cell aplasia

(2016) Robert T. Means   BLOOD

Surgical treatment of thymoma: an 11-year experience with 761 patients

(2015) Yang Zhao et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

(2015) Anish Thomas et al.   LANCET ONCOLOGY

Pemetrexed in patients with thymic malignancies previously treated with chemotherapy

(2015) Ying Liang et al.   LUNG CANCER

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy

(2014) Yusuke Okuma et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

mTOR pathway: A current, up-to-date mini-review (Review)

(2014) PAUL ZAROGOULIDIS et al.   Oncology Letters

Chemotherapy and targeted agents for thymic malignancies

(2012) Nicolas Girard   Expert Review of Anticancer Therapy

Efficacy and Tolerability of long-acting Octreotide in the Treatment of Thymic Tumors

(2011) Flavia Longo et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Epidemiology of Thymoma and Associated Malignancies

(2010) Eric A. Engels   Journal of Thoracic Oncology

The Role of Chemotherapy in Advanced Thymoma

(2010) Jordan Schmitt et al.   Journal of Thoracic Oncology

Everolimus: A Proliferation Signal Inhibitor with Clinical Applications in Organ Transplantation, Oncology, and Cardiology

(2010) Steven Gabardi et al.   PHARMACOTHERAPY

Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)

(2009) G. Palmieri et al.   ANNALS OF ONCOLOGY